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Diurnal Rhythm of Lithogenic Bile and Treatment 
with Chenodeoxycholic Acid 
HIROSHI TANIMURA and YoRINORI HIKASA 
Second Department of Surgery, Faculty of Medicine, Kyoto University 
(Director : Prof. Dr. YoR1NoR1 H1KASA) 
Clinical trials of chenodeoxycholic acid (CDCA) for dissolution of cholesterol gallstones 
have also started in Japanese patients. However, there are some differences of races and 
dietary customs such as in Japanese or Europeans. It is necessary to determine the minimal 
effective dosis in each country concerning these factors. 
In 10 cholecystectomized patients in our clinic, external drainage with T-tube was 
undertaken due to cholesterol or bilirubin-calcium stones in the common bile duct. 40 
samples of 2 ml hepatic bile from T-tube were obtained every three hours without blocking 
enterohepatic circulation after the 10th postoperative day, when they were able to walk ad 
libitum and eat the hospital meals at the regular time. 
After basic sampl巴swere obtained, CDCA was administered at dose of 300 mg at 21:00 
once a day and at dose of 100 mg after each meal on the another day. Chol巴sterol,phos-
pholipids and bile acids in bile and their fractions were measured by TLC and GLC. 
In patients with cholesterol ston巴s, a diurnal rhythm of lithogenic' bile was observed 
and cholesterol supersaturated bile was excreted from evening to midnight. Although 300 
mg of CDCA at 21:00 a day showed sufficient prevention of the production of lithogenic 
bile at next night, 100 mg of CDCA after each meal did not suppress effectively. The 
rhythm of cholesterol supersaturated bile was not observed in patients with bilirubin-calcium 
stones. 
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Present address : Second Department of Surgery, Faculty of Mediciue, Kyoto University, 
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胆汁組成の日内変動とそれに及ぼす chenodeoxycholicacidの影響
表1 胆汁採取スケジュール
午 前 午 f量
AM7・凹（刷責） AMIO・伺 rn宜IPM I : 10 PM 4:帥 （タ宜lPM 7 伺 PMIO，回
’R l目 ① ② ③ ＠ ⑤ ⑥ 
AMI 同 AM4 朗 AM7:00（刷宜l AMIO：師 ｛品賞IPM I：向 p M‘：曲 ｛タ宜lPM 7 伺 午後9時
ll2日
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AMI 曲 A M‘ 個 AM7・帥｛刷宜） AMIO：伺 （外 •1 PM I・佃 PM4・個 ｛夕食lPM? 剖
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Chromosolve W AW60～BO mesh 
8 lt.~2.8nm 
臥ial・wavelengthTLC scanner CS・900





2.5% ov・1Chromosorb WAW60-80mesh 
8ft, 2.8~. u’F形pyrexcolumn 
column temp. 260・c
inj. temp. 290℃ 
carrier . He gas l.Skg/cm' 
carrier He gas I Skg/rm' 
表5 酵素i去による組汁阪の定量
B！什1mf + Folch液（MeOH:CHCb= 1 2) !9ml 
i l!'t件．超音域JOmin. 進沈20min
分耳元2mt （胆i刊.！m1相当）l +(n・Prop…I :Hか 3
f世料、．超高，直， J車，t
分取50μ I + ~￥－ l；液2.Sm!
r品i持（37℃， 45 min) 
↓ 
O.D目岬I~ （λ＝340 nm ) 
1 ) 1 ml 

















た． ζれらの業績は， Nairand Kritchersky著 The
bile acids, Vol. I (1973）および Heaton著 Bile




























































DIURNAL RHYTHM OF CHOLESTEROL HゆLDINGCAPACITY 
CHOLESTEROL STONE 
TIME OF DAY 






























2と同様な実験を行ない， Lithogenic index BA+ 
PL CA （モノレ%〕を縦軸K，時間を横軸（こプロット
40% 
CDCA 300mgH. S. CDCA JOOmgt.i.d.p.c. 
。




























• BASIC RHYTHM 
。： COCA300•• h.• 
x: COCA 100時ti.d.o.c 
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（以下 DCAと略記） リトコール酸（以下 LCAと





































合成の律速酵素である HMG-CoAreductase におい ムを推定し，早朝空腹時に lodoxamicacid による点
ても，コレステロールから胆汁酸への異化における律 滴胆道造影を行った.30分毎lζ胆のう内の造影剤の混
表6
MOL % 附 L % 
PL CH BA LC DC COCA c 
c 23.0 10.0 67.0 0.1 0.7 49.0 50.2 
AM:7 300 19.9 6.9 73.2 0.1 0.0 41.l 58.8 
100 23.8 9.7 66.5 0.1 0.0 34.9 65.0 
朝食ー → c 21. 7 8.6 69.7 0.1 0.6 39.8 59.5 
(JOO) AM: 10 300 15.3 7.5 77.2 0.1 0.0 35.5 64.4 
100 22.9 8.6 68.5 0.1 1.0 44.3 54.6 
昼食一→ c 21.9 9.7 68.4 0.1 0.7 44.7 54.5 
(JOO) PM: 1 300 20.0 7. 7 72.3 0.1 0.0 47.6 52.3 
100 21.8 7.7 70.5 0.1 0.2 41.2 58.6 
c 21.4 7.8 70.8 0.2 1.1 40.9 57.8 
PM:4 300 18.4 8.0 73. 7 0.1 0.0 44.5 55.4 
JOO 12.9 8.2 78.9 0.3 2.3 40.4 57.0 
夕食ー → c 19.0 8.6 72.5 0.2 1. 7 41.9 56.2 
(JOO) PM: 7 300 7.6 6.0 85.9 0.2 1.6 43. 7 54.6 
100 34.3 9. 7 56.0 0.3 1.1 47.9 50. 7 
(300）ー→ c 22.3 9.7 68.0 0.0 1.0 43.5 55.5 
PMIO 300 14.5 6.6 78.9 0.2 0.6 55.8 43.4 
100 23.5 10.8 65. 7 0.2 0.0 39.2 60.6 
c 20.8 12 .1 67 .1 0.2 2.1 41. l 56.7 
AM: 1 300 11.8 5.8 82.4 0.2 1.5 52.3 46.0 
180 22.5 12.9 64.6 0.3 0.0 40. l 59.6 
c 20.2 17 .4 62.4 0.3 0.8 44.5 54.3 
AM:4 300 9.9 4.1 86.0 0.0 0.7 55.7 43.7 
100 17 .4 7.6 75.0 0.2 0.0 39.0 60. 7 









































































































寝前1回投与時の胆汁組成を比較すると， 300 mg 1 
回就寝前投与では胆汁組成は良く改善されるが，
CDCA 100 mg 1日3回ではその改善は不十分であっ
fこ．











なお， 本論文の要旨は， 第61, 62回日ト消化器病学会
(1975. 1976）および：f,10回 International仁ongre"of 
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